How do you monitor response for stage III NSCLC patients receiving consolidation immunotherapy?   

CT or PET? If so, how often?



Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at Providence Western Washington Onc, Inc
This depends somewhat on how much residual disease...
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice

Answer from: Medical Oncologist at Community Practice